Cardiovascular outcomes and mortality risk associated with GLP-1 RAs vs. SGLT-2 inhibitors in patients with incident lung cancer: A target trial emulation

Lung Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles